GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that Justin Gover, GW’s Chief Executive Officer, will present a business update at the following virtual investor conferences: CITI’s 15th Annual BioPharma Virtual Conference 2020 on Thursday, September 10th, 2020 at 4:15pm EDT Morgan Stanl
September 1, 2020
· 2 min read